Check out this FibroKey Grant Program for Academic researchers interested in deeper understanding of Fibrosis using Inoviv’s LC-MS based approach! https://t.co/dptKFiL8mU
Dear #AAIC24 if you think lipid signaling & signatures are important in Alzheimer’s Disease & want to see a result that left us 😮, please check our poster 👀 📷🚫 #AAIC2024#lipidomics
Our latest work is out!
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN‐derived networks and highlights causal links in #Alzheimers led @jinxu2012 @liushi_oxford @petrouliet #openaccess https://t.co/ObTdp5l6Sk
So happy our work is out!
Here we suggest early disease & causal targets for Alzheimer’s disease using metabolomics-proteomics and polygenic risk score data in n~1000 led @liushi_oxford @jinxu2012 @petrouliet 🧵 https://t.co/enV5axqrBI
At the poster session today #Metabolomics2022, please come and visit our posters from @DrLegidoQuigley group! One from Asger @MassSpectacles focusing on ceramides & type 2 diabetes (#577) and the other from @karolina_sulek about microbiota & ALD & metabolites (#675)!
Rosalind Franklin clinical metabolomics award sponsored by Bruker is out now! Nominate yourself! @FemalesInMS, @bruker, https://t.co/Dg4SB4EDtV. In Valencia #MetSoc2022 think already about Copenhagen #NMetC2022. Details can be found here: https://t.co/a5PeAJg8Ze
Share and invite!
I’m co-editing a Special Issue on an important topic for drug development & diagnostics:
“Lipids in Neurodegenerative Disorders”
Looking forward to getting both original research 🔬 papers and excellent reviews 📝
https://t.co/UhGGXjMXZV via @IJMS_MDPI with @lipidomic
Join a Lab Showcase with @DrLegidoQuigley - insight into goals, ambitions, projects, & members discovering clinical tests for diagnostics & new disease treatments. Neuro & metabolic diseases, particularly diseases of brain & liver -> Alzheimer's & Diabetes
https://t.co/xYwNZpSuDd
Our paper, which uses univariable & Bayesian multivariable #MR to investigate whether blood metabolites previously associated with midlife cognition are on the causal pathway to Alzheimer’s Disease, is now out in PNAS 📝 👇🏻https://t.co/ZFHPNYnz1j
Morning! On day 635272 of pandemic life, how about giving our new preprint a read?☺️ We used #PRS to screen for metabolites with genetic relevance to #AD, then #MR to interrogate causal relationships & disentangle possible mediation with cognition factors. Feedback appreciated!🙏🏻
Keen to do a #PhD on shared genetic mechanisms between Alzheimer’s & depression (Project:20 with @cathrynlewis)?
Or use omics data to ID pathways associated with Alzheimer’s (Project 31 with @DrLegidoQuigley & @daniel_stahl_01) ?
Check our projects @ https://t.co/7tsx1GfhM4!
We created a GitHub for the Harvard STAT115/215 BIO/BST282 course: Introduction to Bioinformatics and Computational Biology. https://t.co/gFqsvywtxl. Most of it is based on the 2020 course material, which we will gradually update in spring 2021.
Please tune in to hear our amazing postdoc’s @jinxu2012#AAICNeuroNext presentation on sex-specific biomarkers for Alzheimer’s Disease using the EMIF-AD cohort (Biomarkers (non-neuroimaging): Poster #48649). @DrLegidoQuigley, @KingsIoPPN
Wow! Over 50 attendees have already registered for our next seminar this Fri 6th Nov 12-1pm. Interested in dementia prevention and biomarkers? Register now to secure your place and hear from our talented Working Group Leads @Danielle_Newby and @petrouliet https://t.co/iSYQeKZh4A